OLFML2B Antibody (OALA07515)
- Known as:
- OLFML2B Antibody (OALA07515)
- Catalog number:
- oala07515
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- Aviva Systems Biology
- Gene target:
- OLFML2B Antibody (OALA07515)
Related genes to: OLFML2B Antibody (OALA07515)
- Gene:
- OLFML2B NIH gene
- Name:
- olfactomedin like 2B
- Previous symbol:
- -
- Synonyms:
- DKFZP586L151
- Chromosome:
- 1q23.3
- Locus Type:
- gene with protein product
- Date approved:
- 2004-04-29
- Date modifiied:
- 2016-10-05
Related products to: OLFML2B Antibody (OALA07515)
Related articles to: OLFML2B Antibody (OALA07515)
- Gastric cancer (GC) is among the most frequently diagnosed malignancies worldwide. Identifying novel therapeutic targets is of great significance. - Source: PubMed
Qin XufuHan YuWang ZetaoZhou XiaohuiShi Lijun - BACKGROUND: Bronchiectasis (BE), Chronic Obstructive Pulmonary Disease (COPD) and Primary Immunodeficiency (PID) are distinct respiratory conditions that share features such as chronic inflammation, airway obstruction, and recurrent infections. Despite distinct underlying causes, disease manifestations often overlap clinically, complicating diagnosis and treatment. We aimed to characterise shared and disease-specific immune mechanisms in BE, COPD, and PID using a multi-omics approach across blood and sputum. METHODS: Adults with BE, COPD, PID, and healthy controls underwent serum and sputum protein quantification, sputum proteomics, and transcriptomic profiling of sputum and blood. Neutrophil fractions were included as covariates in transcriptomic analyses. RESULTS: Distinct clinical profiles were observed across disease groups. Serum analyses showed changes in inflammatory and extracellular matrix markers, particularly in BE and COPD. Sputum from BE patients showed elevated inflammatory markers and pathogen burden. Proteomic profiling demonstrated that BE and COPD shared neutrophil-driven inflammatory pathways, while PID exhibited a unique humoral immune signature. Transcriptomic analyses further confirmed neutrophil abundance as a major driver of gene expression variation across disease cohorts. After adjusting for neutrophil fractions, disease-specific differentially expressed genes (DEG) were identified, including OLFML2B, FZD2, and STAB1 in BE, and GPR15, METTL7B, and RNASE1 in COPD. PID samples showed no significant DEGs but enrichment of interferon signalling pathways. CD177 and DEFA3 were overexpressed beyond variation driven by neutrophil abundance, highlighting association with key inflammatory drivers in BE and COPD. CONCLUSIONS: This study uses an integrative multi-omics analysis to improve the understanding of disease heterogeneity and distinct inflammatory pathways in BE, COPD and PID. - Source: PubMed
Publication date: 2026/02/25
Graeter StefanieGonzalez-Jaramillo NathaliaWildschut Mattheus H ECapriotti LuigiSaxenhofer MoritzRobador Jose RamonMonaghan KatherineWoodman NaomiField JudithWilson NickRees MeganHauswald MariaRoca Carlos PFeussner AnnetteSchulze IlkaStewart AlastairSchaub AlexanderChan SamanthaDouglass Jo ASchnell Anna - Gastric cancer (GC) is a prevalent malignancy with high mortality rate. The process of Epithelial-mesenchymal transition (EMT) significantly contributes to its metastasis and resistance to therapy. This research is designed to develop a survival prediction model for EMT-related genes in GC. - Source: PubMed
Publication date: 2025/12/10
Wu JuHuang YananWang XinyueHou ShuanghshuangChang YaoyuanChen XiLi HeXu JianNie ZhequnYin Jiajun - Cancer-associated fibroblasts (CAFs) play a critical role in hepatocellular carcinoma (HCC) progression. This study aimed to develop a CAF-based risk signature model for predicting prognosis and identifying potential therapeutic targets. - Source: PubMed
Publication date: 2025/10/24
Qian WenchenWu KezhiShen ZhuNi BowenZheng HaojieLiu YaweiGuo Manlan - Cellular senescence plays a significant role in tumorigenesis and tumor progression. Substantial evidence indicates that senescence occurs in cancer-associated fibroblasts (CAFs), the predominant stromal component within the tumor microenvironment (TME), which profoundly impacts tumor biology. However, despite growing evidence of stromal cell involvement in cancer progression, the specific mechanisms and clinical implications of senescent CAFs (SCAFs) in hepatocellular carcinoma (HCC) have not been fully elucidated. - Source: PubMed
Publication date: 2025/08/25
Huang HaiPeng WangZhou QiaodanZhao YuchongLiu LuyaoCui HaochenLiang JingwenCao MengdieChen WeiWang RonghuaChen ShiruXiong SiCheng BinBai Shuya